sameAs
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminCirculating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective StudiesHigh-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older menGender differences and disparities in all-cause and coronary heart disease mortality: epidemiological aspectsRecruitment and Screening for the Testosterone TrialsRisk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement StudyElectron beam computed tomography screening and heart disease risk factor modificationEndothelin-1 and prevalent coronary heart disease in older men and women (the Rancho Bernardo Study)Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal womenAssociation of Cardiometabolic Multimorbidity With MortalityLipid-related markers and cardiovascular disease prediction.Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment.Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study.Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsPost hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes.Effects of Testosterone Treatment in Older Men.Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.Birth weight as a predictor of adult bone mass in postmenopausal women: the Rancho Bernardo Study.Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.Demographic factors associated with the diet quality of older US men: baseline data from the Osteoporotic Fractures in Men (MrOS) study.Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.Resting energy expenditure: a better marker than BMI for BMD in African-American women.Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study.Postmenopausal estrogen therapy and selected (less-often-considered) disease outcomes.A1C and diabetes diagnosis: The Rancho Bernardo Study.A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoringGalectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo StudyImported South African tick typhus.Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study.Association of serum bilirubin with aging and mortality.25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men.Grand multiparity is associated with type 2 diabetes in Filipino American women, independent of visceral fat and adiponectin.International travel requirements.Macronutrients, diet quality, and frailty in older menHormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective.Trial of a method of self-screening for gonorrhoea suitable for apprehensive girls.Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study.Hormone replacement therapy: where are we now?
P50
Q22250892-34119A37-F236-4D2E-AFDA-E186620974CEQ22306352-C7182582-FE80-47FE-B603-99682C6F56B8Q24643761-98E7A1D4-B0FB-45CE-A7B4-DD289CA0D859Q27023478-43780017-9A97-44E1-B4C3-EA96C5EDE436Q27301479-27554A46-642E-4360-89B3-BF0634EFB5B4Q28194638-4B253A6A-46C4-469C-AD72-B1692E3DB0D8Q28199585-5261C52A-88FA-47C4-9337-81E72C285C97Q28218930-3107C606-BB9C-4332-9FD3-4B9D8BB0AA14Q28251695-7BBD8128-78D6-4CDB-89F2-C4995ADD110DQ28606934-78074149-E92C-49B9-AA5F-8186918CB436Q28654304-B958BD2C-5EC9-44B0-AE8D-21A4C7099DECQ30410914-6124E600-E6BC-40AD-9B59-0F8AC9E158C6Q30490829-EEAE2C18-C832-4846-96C9-D01CC2AEC986Q30537406-7CA87782-6CAF-4930-8921-6ADD655C75BEQ30708887-5ECEB1BB-B92A-4D60-AE3B-81365FBF48EEQ30810943-D5009636-9C8A-4216-B5C7-B55E88086B9CQ30833686-3EFE8662-E615-43F0-BD83-02BB340E94F6Q30940476-64ED883D-F9F7-4473-A4A8-D64DD09611F9Q30957130-96A8BE38-6FC3-4593-83B3-1C9B7B4A5DC3Q31100823-4944992E-F0B6-42B7-AFA5-994ABD00FF29Q31106741-F6FABCF5-DC69-4A23-8515-C59A30CC851FQ31122463-17036349-B38A-4A14-90E6-958B131D1F6DQ31129827-BF71368C-13F6-424A-8C21-1479921A223FQ33218886-C486B17D-1594-4F55-BC2F-06A4947B514AQ33525190-190CDBDD-9A5D-4B69-92EB-45738DC3AC54Q33547423-8FA2ED27-1B77-4562-83CF-399DA2D1AAB3Q33556703-FD84E602-D869-4ADF-80DD-5644670D9037Q33570209-8DE2B7C3-7C34-474F-86B5-5E3FB7BA0B9DQ33577541-FF01AE03-14D1-4DD2-BDB2-EBBBD26167E7Q33580380-37E917F2-6530-422C-99FA-75BB9509C48AQ33584861-FA3BD01C-BFF3-4B81-BB1A-D110B43A7019Q33595392-D19611FA-D74A-4F04-AF22-5EDC0C043E36Q33601272-C9275938-C750-4EEB-8042-444953850287Q33602303-93D75D3F-B8FC-4822-916A-7041418072F0Q33605554-03FF3C31-7547-4F17-88FD-C353621E2B16Q33616013-F408E06E-8A5F-480D-99A6-16CDD7C2FC9DQ33662542-E0BA1F07-458F-44EB-A1E6-A253A5E49781Q33666886-33B2ED23-8F8C-4446-A96E-1E62A9DCAD7EQ33729824-DEA05D19-1155-43D3-BB0E-1768C698D3D6Q33731351-74DA32D8-A997-4E91-BBB4-41881DB150A2
P50
subject
description
Amerikaans onderzoekster (1935-2019)
@nl
founder of The Rancho Bernardo ...... on-based study of older adults
@en
name
Elizabeth Barrett-Connor
@ast
Elizabeth Barrett-Connor
@en
Elizabeth Barrett-Connor
@es
Elizabeth Barrett-Connor
@ga
Elizabeth Barrett-Connor
@nl
Elizabeth Barrett-Connor
@sl
type
label
Elizabeth Barrett-Connor
@ast
Elizabeth Barrett-Connor
@en
Elizabeth Barrett-Connor
@es
Elizabeth Barrett-Connor
@ga
Elizabeth Barrett-Connor
@nl
Elizabeth Barrett-Connor
@sl
altLabel
Elizabeth L. Barrett Connor
@ast
Elizabeth L. Barrett Connor
@en
Elizabeth Louise Barrett
@en
prefLabel
Elizabeth Barrett-Connor
@ast
Elizabeth Barrett-Connor
@en
Elizabeth Barrett-Connor
@es
Elizabeth Barrett-Connor
@ga
Elizabeth Barrett-Connor
@nl
Elizabeth Barrett-Connor
@sl
P106
P166
P1006
P214
P244
P1006
P1153
35377249400
P1207
P1477
Elizabeth Louise Barrett
@en
P166
P19
P20
P21
P213
0000 0001 1155 3178
P214
P244
n2001130936
P31
P569
1935-04-08T00:00:00Z
P570
2019-06-09T00:00:00Z
P7859
lccn-n2001130936